An interrogation of the whole genomes of more than 2,600 cancers yields clues about the genetic drivers of malignancy, how tumors evolve, and more.

The East Coast campus of the research institute received shipments of freeze-dried or frozen samples of more than 210,000 microbial strains, which scientists plan to mine for potentially useful natural products.

Trophoblasts, collected from the mother during a blood draw, can determine fetal genetic abnormalities currently diagnosed through amniocentesis or chorionic villi sampling.

Sequences from dozens of ancient remains from Siberia reveal the closest ancient relative of Native Americans found outside of North America.

A trial called BabySeq, in which researchers performed genomic sequencing on 159 newborns, identified children susceptible to diseases that regular screening doesn’t look for.

Nebula Genomics is among the first blockchain-based companies to reward users for contributing personal data for research.

Luna DNA, Nebula Genomics, and other “bio-brokers” will allow customers to make money by granting access to their genetic and personal information for research purposes.

Researchers at the Rare Genomics Institute look at how families finance the cost of diagnostic exome sequencing.

Two large-scale studies reveal new insights into the genomic characteristics of childhood cancers.